MBX-102

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 2

Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin

CompletedNCT00353587

Gilead SciencesType 2 Diabetes

Start: 2006-05-31End: 2007-11-30Updated: 2015-05-01

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

TerminatedNCT00814372

Gilead SciencesType 2 Diabetes Mellitus

Start: 2008-12-01End: 2010-02-01Updated: 2026-09-18

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01